Background: ChEVAR becoming very popular option to treat juxtarenal AAA in emergency or urgent situation. The technique is very diverse and this result in conflict data about the outcome and the rate of type 1 endoleak. Method(s): In this presentation i will review the steps and tricks in ChEVAR deployment for best outcome and review literature comparing ChEVAR with FEVAR. Result(s): Chevar has very good outcome with very low rate of type 1 endoleake if carried out in standard technique. These results are very comparable with FEVAR. Conclusion(s): Chevar is an alternative technique to treat juxtarenal AAA especially in emergency situation and it carry very low rate of type 1 endoleak if deployed correctly.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.